pharmaphorum

AUGUST 21, 2022

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. Auvelity is the first drug Axsome has taken through to regulatory approval, but could be the first of a string of new products for the company, according to Tabuteau.

FDA 98

FDA Labelling 98

pharmaphorum

MAY 17, 2021

There had been speculation that the FDA might approve Empaveli (pegcetacoplan) only as a backup option for patients who don’t see a sufficient benefit with Alexion’s Soliris (eculizumab) or Ultomiris (ravulizumab), but the regulator opted for a broad indication that included first-line treatment for PNH. billion and $1.1

FDA 52

FDA Labelling Vaccines 52

The Checkup by Singlecare

DECEMBER 5, 2023

The #ozempic tag on TikTok has amassed over 1 billion views to date. Contrave (naltrexone-bupropion): Contrave is a combination of a substance abuse medication and an antidepressant that’s thought to regulate appetite in the brain. Ozempic became one of the most talked about drugs in 2023. The Type 2 diabetes medication was everywhere.

Insurance 105

Insurance Prescription Filling FDA Dosage 105

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. And my estimate is that between 25,000 and 30,000 patients have been treated with those therapies globally, which does not include patients treated in clinical trials.

FDA 59

FDA Immunization 59

The Checkup by Singlecare

NOVEMBER 2, 2023

These drugs mimic GLP-1, a hormone responsible for regulating appetite and food intake, leading to weight loss and improved control of blood sugar levels in people with Type 2 diabetes. Both GIP and GLP-1 hormones are involved in regulating hunger and food intake. A 2020 clinical trial demonstrates this point.

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

PharmaShots

MARCH 9, 2023

An elected member of Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI), she also serves fellow of the American Gastroenterological Association. and medical doctor in clinical pharmacology Other Affiliations: She is a member of the Board of Directors of L’Oréal S.A

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

The Checkup by Singlecare

JUNE 21, 2023

The condition causes higher levels of androgen hormone production, resulting in symptoms such as irregular menstrual cycles, acne, excess hair growth, cysts, skin tags, thinning hair, skin darkening, and infertility. That is, semaglutide has been shown to improve hormone regulation and metabolism, resulting in weight loss.

Insurance 98

Insurance FDA Compounding Compounding Pharmacies 98